REPORT ID 6620

EMEA (Europe, Middle East and Africa) Radiopharmaceuticals Market Report 2017

Publish Date
26-Dec-17
Pages
116
Format
Electronic (PDF)

In this report, the EMEA Radiopharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Radiopharmaceuticals for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Radiopharmaceuticals market competition by top manufacturers/players, with Radiopharmaceuticals sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Bracco Imaging
    Bayer
    Mallinckrodt
    Nordion
    Triad Isotopes
    Lantheus
    IBA Group
    GE Healthcare
    China Isotope & Radiation
    Jubilant Pharma
    Eli Lilly
    Advanced Accelerator Applications
    SIEMENS
    Dongcheng
    Navidea

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Diagnostic Radioisotopes
    Therapeutic Radioisotopes

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Oncology
    Cardiology
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Radiopharmaceuticals Market Report 2017
1 Radiopharmaceuticals Overview
    1.1 Product Overview and Scope of Radiopharmaceuticals
    1.2 Classification of Radiopharmaceuticals
        1.2.1 EMEA Radiopharmaceuticals Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Radiopharmaceuticals Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Diagnostic Radioisotopes
        1.2.4 Therapeutic Radioisotopes
    1.3 EMEA Radiopharmaceuticals Market by Application/End Users
        1.3.1 EMEA Radiopharmaceuticals Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Oncology
        1.3.3 Cardiology
        1.3.4 Other
    1.4 EMEA Radiopharmaceuticals Market by Region
        1.4.1 EMEA Radiopharmaceuticals Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Radiopharmaceuticals (2012-2022)
        1.5.1 EMEA Radiopharmaceuticals Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Radiopharmaceuticals Revenue and Growth Rate (2012-2022)

2 EMEA Radiopharmaceuticals Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Radiopharmaceuticals Market Competition by Players/Manufacturers
        2.1.1 EMEA Radiopharmaceuticals Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Radiopharmaceuticals Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Radiopharmaceuticals Sale Price by Players (2012-2017)
    2.2 EMEA Radiopharmaceuticals (Volume and Value) by Type/Product Category
        2.2.1 EMEA Radiopharmaceuticals Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Radiopharmaceuticals Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Radiopharmaceuticals Sale Price by Type (2012-2017)
    2.3 EMEA Radiopharmaceuticals (Volume) by Application
    2.4 EMEA Radiopharmaceuticals (Volume and Value) by Region
        2.4.1 EMEA Radiopharmaceuticals Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Radiopharmaceuticals Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Radiopharmaceuticals Sales Price by Region (2012-2017)

3 Europe Radiopharmaceuticals (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Radiopharmaceuticals Sales and Value (2012-2017)
        3.1.1 Europe Radiopharmaceuticals Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Radiopharmaceuticals Revenue and Growth Rate (2012-2017)
    3.2 Europe Radiopharmaceuticals Sales and Market Share by Type
    3.3 Europe Radiopharmaceuticals Sales and Market Share by Application
    3.4 Europe Radiopharmaceuticals Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Radiopharmaceuticals Sales Volume by Countries (2012-2017)
        3.4.2 Europe Radiopharmaceuticals Revenue by Countries (2012-2017)
        3.4.3 Germany Radiopharmaceuticals Sales and Growth Rate (2012-2017)
        3.4.4 France Radiopharmaceuticals Sales and Growth Rate (2012-2017)
        3.4.5 UK Radiopharmaceuticals Sales and Growth Rate (2012-2017)
        3.4.6 Russia Radiopharmaceuticals Sales and Growth Rate (2012-2017)
        3.4.7 Italy Radiopharmaceuticals Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Radiopharmaceuticals Sales and Growth Rate (2012-2017)

4 Middle East Radiopharmaceuticals (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Radiopharmaceuticals Sales and Value (2012-2017)
        4.1.1 Middle East Radiopharmaceuticals Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Radiopharmaceuticals Revenue and Growth Rate (2012-2017)
    4.2 Middle East Radiopharmaceuticals Sales and Market Share by Type
    4.3 Middle East Radiopharmaceuticals Sales and Market Share by Application
    4.4 Middle East Radiopharmaceuticals Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Radiopharmaceuticals Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Radiopharmaceuticals Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Radiopharmaceuticals Sales and Growth Rate (2012-2017)
        4.4.4 Israel Radiopharmaceuticals Sales and Growth Rate (2012-2017)
        4.4.5 UAE Radiopharmaceuticals Sales and Growth Rate (2012-2017)
        4.4.6 Iran Radiopharmaceuticals Sales and Growth Rate (2012-2017)

5 Africa Radiopharmaceuticals (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Radiopharmaceuticals Sales and Value (2012-2017)
        5.1.1 Africa Radiopharmaceuticals Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Radiopharmaceuticals Revenue and Growth Rate (2012-2017)
    5.2 Africa Radiopharmaceuticals Sales and Market Share by Type
    5.3 Africa Radiopharmaceuticals Sales and Market Share by Application
    5.4 Africa Radiopharmaceuticals Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Radiopharmaceuticals Sales Volume by Countries (2012-2017)
        5.4.2 Africa Radiopharmaceuticals Revenue by Countries (2012-2017)
        5.4.3 South Africa Radiopharmaceuticals Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Radiopharmaceuticals Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Radiopharmaceuticals Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Radiopharmaceuticals Sales and Growth Rate (2012-2017)

6 EMEA Radiopharmaceuticals Manufacturers/Players Profiles and Sales Data
    6.1 Bracco Imaging
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Radiopharmaceuticals Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Bayer
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Radiopharmaceuticals Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Bayer Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Mallinckrodt
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Radiopharmaceuticals Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Nordion
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Radiopharmaceuticals Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Nordion Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Triad Isotopes
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Radiopharmaceuticals Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Lantheus
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Radiopharmaceuticals Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Lantheus Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 IBA Group
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Radiopharmaceuticals Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 IBA Group Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 GE Healthcare
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Radiopharmaceuticals Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 China Isotope & Radiation
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Radiopharmaceuticals Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Jubilant Pharma
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Radiopharmaceuticals Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Eli Lilly
    6.12 Advanced Accelerator Applications
    6.13 SIEMENS
    6.14 Dongcheng
    6.15 Navidea

7 Radiopharmaceuticals Manufacturing Cost Analysis
    7.1 Radiopharmaceuticals Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Radiopharmaceuticals

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Radiopharmaceuticals Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Radiopharmaceuticals Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Radiopharmaceuticals Market Forecast (2017-2022)
    11.1 EMEA Radiopharmaceuticals Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Radiopharmaceuticals Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Radiopharmaceuticals Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Radiopharmaceuticals Price and Trend Forecast (2017-2022)
    11.2 EMEA Radiopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Radiopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Radiopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Radiopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Radiopharmaceuticals Sales Forecast by Type (2017-2022)
    11.7 EMEA Radiopharmaceuticals Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer